Metformin: Beyond Diabetes
The most widely prescribed diabetes drug is being repurposed for longevity. The TAME trial aims to prove metformin targets the root cause of aging.
Last updated: March 2026
Dose Range
For Diabetes
Longevity Trial
📋 On this page
What Is Metformin?
Metformin is a first-line medication for type 2 diabetes, prescribed since 1957. It works by activating AMPK (AMP-activated protein kinase) — the cellular energy sensor — and reducing liver glucose production. More recently, it's been studied as a longevity compound due to observational data showing reduced age-related diseases in diabetic patients.
Metformin activates AMPK, the master regulator of cellular energy. This triggers glucose uptake, improves insulin sensitivity, and activates autophagy — cellular cleanup.
Indirectly inhibits mTOR (like rapamycin but through different pathways). Combined AMPK activation + mTOR inhibition is a powerful anti-aging combination.
Targeting Aging with Metformin — the landmark trial designed to prove that metformin treats the root cause of aging, not just symptoms. First "anti-aging" drug trial.
Multiple studies show metformin users have reduced all-cause mortality, cardiovascular disease, cancer, and cognitive decline vs non-diabetics and even non-metformin diabetics.
What the Research Shows
Key insight: Most data is observational (diabetics on metformin vs those not). The TAME trial will provide RCT evidence. Non-diabetic use is off-label.
Longevity Dosing
- • Start: 500mg daily (low to reduce GI)
- • Build to: 1000-1500mg daily
- • Take with meals (reduces GI side effects)
- • XR (extended-release) may be better tolerated
- • May blunt exercise-induced benefits
- • Controversial — not confirmed in all studies
- • Some users cycle off on workout days
- • More research needed
Side Effects
• GI upset: Nausea, diarrhea, stomach pain (very common, especially initially)
• B12 deficiency: Long-term use depletes B12 — supplement
• Lactic acidosis: Rare but serious — contraindicated in kidney disease
• Start low: 500mg with dinner, increase slowly
Key Takeaways
- Prescribed since 1957 — well-understood safety
- Strong observational mortality reduction data
- AMPK + mTOR dual mechanism
- TAME trial will provide RCT evidence
- Inexpensive and accessible
- Whether non-diabetics benefit
- Optimal longevity dose
- Exercise blunting — controversial
- Long-term effects in healthy people
🛒 Recommended Products
Related Resources
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Get the Guide →
This page is for educational purposes only. Metformin is a prescription drug. Off-label use for longevity requires medical supervision. Consult a healthcare provider.